Please use this identifier to cite or link to this item: https://doi.org/10.1007/s12070-011-0258-y
DC FieldValue
dc.titleThe MicroFlow Spacer: A Drug-Eluting Stent for the Ethmoid Sinus
dc.contributor.authorCatalano, P.J.
dc.contributor.authorThong, M.
dc.contributor.authorWeiss, R.
dc.contributor.authorRimash, T.
dc.date.accessioned2016-07-08T09:28:59Z
dc.date.available2016-07-08T09:28:59Z
dc.date.issued2011-07
dc.identifier.citationCatalano, P.J., Thong, M., Weiss, R., Rimash, T. (2011-07). The MicroFlow Spacer: A Drug-Eluting Stent for the Ethmoid Sinus. Indian Journal of Otolaryngology and Head and Neck Surgery 63 (3) : 279-284. ScholarBank@NUS Repository. https://doi.org/10.1007/s12070-011-0258-y
dc.identifier.issn22313796
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/125591
dc.description.abstractTo evaluate the short-term outcomes and safety of a newly introduced drug-eluting ethmoid stent. Prospective study of 23 patients with a total of 40 implanted ethmoid sinuses. Two tertiary care medical facility. Twenty-three patients with medically refractory chronic rhinosinusitis were treated with patient-appropriate endoscopic sinus surgery, with the modification of treating the ethmoid sinuses with an ethmoid stent infused with triamcinolone, instead of conventional endoscopic ethmoidectomy. Patients were then followed up over 6 months. Outcomes were assessed by interval changes in 20-item Sino-Nasal Outcome Test (SNOT-20) and Lund-MacKay CT scores. Safety was determined by adverse events. Overall, the pre-op SNOT-20 mean score was 2. 18, versus post-op score of 1. 02, an improvement of 1. 16 that was both statistically (P < 0. 001) and clinically significant. Ethmoid-specific and side-specific Lund-MacKay mean scores both also showed statistically significant improvements. Pre-op ethmoid-specific Lund-MacKay mean score was 1. 93, versus post-op score of 1. 10, an improvement of 0. 83 (P < 0. 001). Pre-op side-specific Lund-MacKay mean score was 5. 75, compared with post-op score of 2. 95, an improvement of 2. 80 (P < 0. 001). There were no significant intra-op or post-op complications encountered. This triamcinolone-infused ethmoid stent appears safe and effective in treating chronic ethmoid sinus disease within the defined follow-up period. The ability to deliver medication directly to diseased mucosa holds wide-ranging potential. © 2011 Association of Otolaryngologists of India.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1007/s12070-011-0258-y
dc.sourceScopus
dc.subjectDrug
dc.subjectElution
dc.subjectEthmoid
dc.subjectSinus
dc.subjectStent
dc.typeArticle
dc.contributor.departmentOTOLARYNGOLOGY
dc.description.doi10.1007/s12070-011-0258-y
dc.description.sourcetitleIndian Journal of Otolaryngology and Head and Neck Surgery
dc.description.volume63
dc.description.issue3
dc.description.page279-284
dc.description.codenIONSF
dc.identifier.isiut000292886100017
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

22
checked on Nov 21, 2022

WEB OF SCIENCETM
Citations

20
checked on Nov 21, 2022

Page view(s)

170
checked on Nov 24, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.